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General: All reactions were carried out at room temperature in sealed tubes under a nitrogen 
atmosphere. All (NHC)AuNTf2 and (phosphine)AuNTf2 catalysts were prepared according to 
procedures reported by Gagosz.[1] All aldehydes, alcohols and alkynes used in Tables 1-2 and 
Equation 1 were purchased from commercial sources (Sigma-Aldrich Chemical Co. or Acros 
Chemical Co.) and used without further purification. Compounds 29 and 31 in Equations 3–4 
were purchased from Sigma-Aldrich Chemical Co. and used without further purification. 
Dichloromethane was purified using a GlassContour solvent purification system. Structural and 
stereochemical assignments were made on the basis of 2-D COSY, HSQC, and NOESY 
experiments. Ratios of diastereomers were determined by 1H NMR analysis. Yields refer to 
isolated yields of compounds estimated to be ≥95% pure as determined by 
1
H NMR analysis 
unless otherwise noted.  
 
Synthesis and Characterization of β-Alkoxy Ketone Products 
 
 S2 
General procedure: Au(I)-catalyzed synthesis of β-alkoxy ketones. An oven-dried test tube 
was equipped with a magnetic stir bar and cooled under a stream of N2 before being charged 
with SPhosAuNTf2 (5 mol%). The tube was then charged with a 0.1 M CH2Cl2 solution of 
aldehyde (1 equiv), alkyne (1.5 equiv) and alcohol (3 equiv) before being sealed with a septum. 
The resulting mixture was stirred at room temperature and monitored by TLC analysis. After the 
starting material was consumed, the mixture was concentrated in vacuo and purified by flash 
chromatography on silica gel using hexanes/ethyl acetate as the eluent.  
 
 
3-(4-Bromophenyl)-3-methoxy-1-phenylpropan-1-one (10). The reaction of 2-
chlorobenzaldehyde (65 mg, 0.35 mmol) with phenylacetylene (59 µl, 0.53 mmol) and methanol 
(43 µl, 1.05 mmol) was conducted according to the general procedure. This procedure afforded 
65 mg (59%) of the title compound as a pale yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.91 (d, J = 
7.5 Hz, 2 H), 7.55 (t, J = 7.0 Hz, 1 H), 7.49 (d, J = 8.0 Hz, 2 H), 7.44 (t, J = 7.5 Hz, 2 H), 7.28 (d, 
J = 8.0 Hz, 2 H), 4.84 (dd, J = 5.0, 8.0 Hz, 1 H), 3.56 (dd, J = 8.0, 16.5 Hz, 1 H), 3.22 (s, 3 H), 
3.06 (dd, J = 4.5, 16.5 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 197.3, 140.5, 136.9, 133.2, 
131.7, 128.6, 128.4, 128.2, 121.7, 78.9, 56.9, 46.9; IR (film) 3052, 1688, 1265, 1098 cm–1. MS 
(ESI) 341.0159 (341.0148 calcd for C16H15BrO2, M + Na+). 
 
 
3-(4-Bromophenyl)-1-(3-chlorophenyl)-3-methoxypropan-1-one (15). The reaction of 4-
bromobenzaldehyde (30 mg, 0.16 mmol) with 3-chloro-1-ethynylbenzene (30 µl, 0.24 mmol) and 
methanol (20 µl, 0.48 mmol) was conducted according to the general procedure using 5 mol% 
of JohnPhosAuNTf2 in place of SPhosAuNTf2. This procedure afforded 40 mg (69%) of the title 
compound as an off white solid: mp = 68–70 °C. 1H NMR (500 MHz, CDCl3) δ 7.89 (s, 1 H), 7.79 
(d, J = 8.0 Hz, 1 H), 7.51 (d, J = 8.0 Hz, 1 H), 7.49 (d, J = 9.0 Hz, 2 H), 7.39 (t, J = 8.0 Hz, 1 H), 
7.28 (d, J = 8.0 Hz, 2 H), 4.82 (dd, J = 4.5, 8.0 Hz, 1 H), 3.52 (dd, J = 8.5, 16.5 Hz, 1 H), 3.21 (s, 
3 H), 3.01 (dd, J = 4.5, 16.5 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 196.0, 140.2, 138.5, 134.9, 
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133.1, 131.7, 129.9, 128.4, 128.3, 126.3, 121.8, 78.8, 56.9, 47.0; IR (film) 3052, 1690, 1421, 
1265, 1098 cm–1. MS (ESI) 374.9754 (374.9758 calcd for C16H14BrClO2, M + Na+). 
 
 
3-Methoxy-3-(4-methoxyphenyl)-1-phenylpropan-1-one (16). The reaction of p-anisaldehyde 
(40 mg, 0.29 mmol) with phenylacetylene (49 µl, 0.44 mmol) and methanol (35 µl, 0.87 mmol) 
was conducted according to the general procedure. This procedure afforded 54 mg (69%) of the 
title compound as an orange oil. 1H NMR (500 MHz, CDCl3) δ 7.94 (d, J = 8.5 Hz, 2 H), 7.54 (t, J 
= 7.5 Hz, 1 H), 7.44 (t, J = 8.0 Hz, 2 H), 7.33 (d, J = 7.0 Hz, 2 H), 6.91 (d, J = 6.5 Hz, 2 H); 13C 
NMR (125 MHz, CDCl3) δ 197.8, 159.3, 137.2, 133.4, 133.0, 128.5, 128.2, 127.9, 113.9, 79.1, 
56.6, 55.2, 47.1; IR (film) 3053, 1684, 1511, 1264, 1172 cm–1. MS (ESI) 293.1154 (293.1148 
calcd for C17H18O3, M + Na+). 
 
 
1-(4-Fluorophenyl)-3-methoxy-3-(4-methoxyphenyl)propan-1-one (17). The reaction of p-
anisaldehyde (40 mg, 0.29 mmol) with 1-ethynyl-4-fluorobenzene (50 µl, 0.44 mmol) and 
methanol (59 µl, 1.47 mmol) was conducted according to the general procedure. This procedure 
afforded 68 mg (81%) of the title compound as an orange oil. 1H NMR (400 MHz, CDCl3) δ 
7.97–7.93 (m, 2 H), 7.29 (d, J = 8.4 Hz, 2 H), 7.10–7.06 (m, 2 H), 6.88 (d, J = 8.4 Hz, 2 H), 4.78 
(dd, J = 4.8, 8.4 Hz, 1 H), 3.79 (s, 3 H), 3.53 (dd, J = 8.4, 16.4 Hz, 1 H), 3.18 (s, 3 H), 3.01 (dd, 
J = 4.8, 16.4 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 196.2, 165.6 (d, J = 254.6 Hz), 159.2, 
133.6 (d, J = 3.1 Hz), 133.1, 130.8 (d, J = 9.3 Hz), 127.8, 115.5 (d, J = 21.8 Hz), 113.9, 79.1, 
56.5, 55.2, 46.9; IR (film) 3053, 1684, 1598, 1511, 1264, 1156 cm–1. MS (ESI) 311.1059 
(311.1054 calcd for C17H17FO3, M + Na+). 
 
 
3-(2-Chlorophenyl)-3-methoxy-1-phenylpropan-1-one (18). The reaction of 2-
chlorobenzaldehyde (40 mg, 0.28 mmol) with phenylacetylene (44 µl, 0.43 mmol) and methanol 
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(34 µl, 0.84 mmol) was conducted according to the general procedure using 5 mol% of 
JohnPhosAuNTf2 in place of SPhosAuNTf2. This procedure afforded 54 mg (69%) of the title 
compound as a pale yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 8.0 Hz, 2 H), 7.58–7.54 
(m, 2 H), 7.45 (t, J = 8.0 Hz, 2 H), 7.37 (d, J = 8.0 Hz, 1 H), 7.33 (t, J = 7.5 Hz, 1 H), 7.24 (t, J = 
7. 5 Hz, 1 H), 5.34 (dd, J = 3.0, 9.5 Hz, 1 H), 3.39 (dd, J = 9.5, 16.5 Hz, 1 H), 3.28 (s, 3 H), 3.15 
(dd, J = 3.0, 16.5 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 197.1, 138.9, 136.9, 133.1, 132.6, 
129.6, 128.7, 128.5, 128.2, 127.3, 127.2, 76.1, 57.4, 45.5; IR (film) 3053, 1684, 1264, 1107 cm–
1. MS (ESI) 297.0655 (297.0653 calcd for C16H15ClO2, M + Na+). 
 
 
(E)-1-(4-Fluorophenyl)-3-methoxy-5-phenylpent-4-en-1-one (19). The reaction of trans-
cinnamaldehyde (40 mg, 0.30 mmol) with 1-ethynyl-4-fluorobenzene (52 µl, 0.45 mmol) and 
methanol (36 µl, 0.90 mmol) was conducted according to the general procedure. This procedure 
afforded 48 mg (56%) of the title compound as an orange oil. 1H NMR (500 MHz, CDCl3) δ 7.99 
(t, J = 7.5 Hz, 2 H), 7.39 (d, J = 8.5 Hz, 2 H), 6.66 (d, J = 16.0 Hz, 1 H), 6.15 (dd, J = 7.5, 16.0 
Hz, 1 H), 4.44 (ddd, J = 4.5, 8.0, 8.0 Hz, 1 H), 3.43 (dd, J = 8.0, 16.5 Hz, 1 H), 3.33 (s, 3 H), 
3.01 (dd, J = 4.5, 16.0 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 196.1, 165.7 (d, J = 254.2 Hz), 
136.2, 133.6 (d, J = 2.9 Hz), 132.6, 130.9 (d, J = 8.8 Hz), 128.6, 128.5, 127.9, 126.5, 115.6 (d, J 
= 21.6 Hz), 78.3, 56.6, 44.7; IR (film) 3053, 2985, 1686, 1598, 1506, 1265, 1156 cm–1. MS (ESI) 
307.1111 (307.1105 calcd for C18H17FO2, M + Na+). 
 
 
3-(Allyloxy)-3-(benzo[d][1,3]dioxol-5-yl)-1-phenylpropan-1-one (20). The reaction of 
piperonal (39 mg, 0.26 mmol) with phenylacetylene (43 µl, 0.39 mmol) and allyl alcohol (53 µl, 
0.78 mmol) was conducted according to the general procedure. This procedure afforded 52 mg 
(64%) of the title compound as a yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 7.0 Hz, 2 
H), 7.53 (t, J = 7.5 Hz, 1 H), 7.43 (t, J = 7.5 Hz, 2 H), 6.92 (s, 1 H), 6.85 (d, J = 8.0 Hz, 1 H), 
6.77 (d, J = 8.0 Hz, 1 H), 5.94 (d, J = 4.0 Hz, 2 H), 5.87–5.79 (m, 1 H), 5.19–5.09 (m, 2 H), 4.95 
(dd, J = 5.0, 8.0 Hz, 1 H), 3.92–3.88 (m, 1 H), 3.80 (dd, J = 6.0, 12.5 Hz, 1 H), 3.58 (dd, J = 8.0, 
16.5 Hz, 1 H), 3.09 (dd, J = 5.0, 16.5 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 197.6, 147.9, 
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147.2, 137.2, 135.6, 134.6, 133.1, 128.5, 128.2, 120.3, 116.9, 108.1, 106.9, 101.0, 77.1, 69.5, 
47.2; IR (film) 3053, 1686, 1487, 1264, 1040 cm–1. MS (ESI) 333.1110 (333.1097 calcd for 
C19H18O4, M + Na+). 
 
 
(2S)-3-(4-Bromophenyl)-3-(2-methylbutoxy)-1-phenylpropan-1-one (21). The reaction of 4-
bromobenzaldehyde (40 mg, 0.22 mmol) with phenylacetylene (36 µl, 0.32 mmol) and (S)-2-
methylbutan-1-ol (71 µl, 0.66 mmol) was conducted according to the general procedure. This 
procedure afforded 57 mg (69%) of the title compound as a 1:1 mixture of diastereomers that 
were inseparable by flash chromatography. Data are for the mixture. 1H NMR (400 MHz, CDCl3) 
δ 7.91 (d, J = 7.2 Hz, 2 H), 7.53 (t, J = 5.6 Hz, 1 H), 7.48–7.41 (m, 4 H), 7.27 (d, J = 8.4 Hz, 2 
H), 4.87 (dd, J = 5.2, 8.8 Hz, 1 H), 3.55 (dd, J = 8.4, 16.0 Hz, 1 H), 3.15–3.11 (m, 1 H), 3.08–
3.03 (m, 1 H), 2.99 (ddd, J = 2.4, 4.8, 16.4 Hz, 1 H), 1.54–1.48 (m, 1 H), 1.36–1.26 (m, 1 H), 
1.05–0.95 (m, 1 H), 0.78-0.76 (m, 6 H); 13C NMR (100 MHz, CDCl3) δ 197.7, 141.3, 137.3, 
133.1, 131.6, 128.5, 128.4, 128.3, 128.2, 121.4, 77.8, 77.7, 74.5, 74.4, 47.2, 35.0, 34.9, 26.1, 
26.0, 16.6, 16.4, 11.3, 11.2; IR (film) 3053, 1684, 1511, 1264, 1010 cm–1. MS (ESI) 397.0775 
(397.0774 calcd for C20H23BrO2, M + Na+).  
 
 
1-(3-Chlorophenyl)-3-(4-methoxyphenyl)-3-(3-phenylpropoxy)propan-1-one (22). The 
reaction of p-anisaldehyde (35 mg, 0.26 mmol) with 3-chloro-1-ethynylbenzene (48 µl, 0.39 
mmol) and 3-phenyl-1-propanol (106 mg, 0.78 mmol) was conducted according to the general 
procedure. This procedure afforded 56 mg (53%) of the title compound as a yellow oil. 1H NMR 
(500 MHz, CDCl3) δ 7.95 (s, 1 H), 7.84 (d, J = 8.0 Hz, 1 H), 7.50 (d, J = 7.5 Hz, 1 H), 7.38 (t, J = 
7.5 Hz, 1 H), 7.31 (d, J = 8.5 Hz, 2 H), 7.23 (t, J = 7.0 Hz, 2 H), 7.14 (t, J = 7.5 Hz, 1 H), 7.08 (d, 
J = 8.5 Hz, 2 H), 6.90 (d, J = 8.5 Hz, 2 H), 4.87 (dd, J = 4.5, 8.5 Hz, 1 H), 3.80 (s, 3 H), 3.57 (dd, 
J = 8.5, 16.0 Hz, 1 H), 3.55–3.31 (m, 1 H), 3.29–3.24 (m, 1 H), 3.00 (dd, J = 4.5, 16.0 Hz, 1 H), 
2.61–2.49 (m, 2 H), 1.80–1.74 (m, 2 H); 13C NMR (125 MHz, CDCl3) δ 196.9, 159.3, 142.1, 
139.0, 134.8, 133.7, 132.9, 129.8, 128.5, 128.4, 128.2, 127.8, 126.4, 125.7, 113.9, 77.8, 67.9, 
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55.3, 47.4, 32.3, 31.4; IR (film) 3052, 1689, 1511, 1263, 1098 cm–1. MS (ESI) 431.1383 
(431.1384 calcd for C25H25ClO3, M + Na+). 
 
 
3-(4-Bromophenyl)-3-(cyclohexyloxy)-1-phenylpropan-1-one (23). The reaction of 4-
bromobenzaldehyde (40 mg, 0.22 mmol) with phenylacetylene (36 µl, 0.32 mmol) and 
cyclohexanol (64 mg, 0.64 mmol) was conducted according to the general procedure. This 
procedure afforded 48 mg (57%) of the title compound as a yellow oil. 1H NMR (400 MHz, 
CDCl3) δ 7.91 (d, J = 8.0 Hz, 2 H), 7.53 (t, J = 7.2 Hz, 1 H), 7.46–7.40 (m, 4 H), 7.30 (d, J = 8.8 
Hz, 2 H), 5.09 (dd, J = 4.8, 8.4 Hz, 1 H), 3.53 (dd, J = 8.4, 15.9 Hz, 1 H), 3.19–3.13 (m, 1 H), 
2.96 (dd, J = 4.4, 15.9 Hz, 1 H), 1.87–1.84 (m, 1 H), 1.63–1.55 (m, 3 H), 1.41–1.39 (m, 1 H), 
1.24–1.07 (m, 6 H); 13C NMR (100 MHz, CDCl3) δ 197.8, 142.3, 137.3, 133.1, 131.5, 128.5, 
128.3, 128.2, 121.2, 75.6, 74.4, 47.7, 33.4, 31.1, 25.7, 24.0, 23.8; IR (film) 3052, 2933, 1685, 
1448, 1265, 1010 cm–1. MS (ESI) 409.0783 (409.0774 calcd for C21H23BrO2, M + Na+). 
 
 
(E)-3-(Cyclobutylmethoxy)-1,5-diphenylpent-4-en-1-one (24). The reaction of trans-
cinnamaldehyde (42 mg, 0.32 mmol) with phenylacetylene (49 µl, 0.45 mmol) and 
cyclobutanemethanol (86 µl, 0.91 mmol) was conducted according to the general procedure. 
This procedure afforded 43 mg (42%) of the title compound as a yellow oil. 1H NMR (500 MHz, 
CDCl3) δ 7.98 (d, J = 7.5 Hz, 2 H), 7.55 (t, J = 7.5 Hz, 1 H), 7.46 (t, J = 7.5 Hz, 2 H), 7.40 (d, J = 
7.5 Hz, 2 H), 7.32 (t, J = 7.5 Hz, 2 H), 7.24 (t, J = 7.0 Hz, 1 H), 6.65 (d, J = 16.0 Hz, 1 H), 6.19 
(dd, J = 7.5, 16.0 Hz, 1 H), 4.54 (dd, J = 7.0, 13.0 Hz, 1 H), 3.55 (dd, J = 7.0, 9.5 Hz, 1 H), 3.47 
(dd, J = 8.0, 16.0 Hz, 1 H), 3.35 (dd, J = 6.5, 9.5 Hz, 1 H), 3.04 (dd, J = 5.5, 16.0 Hz, 1 H), 2.53–
2.50 (m, 1 H), 2.00–1.95 (m, 2 H), 1.89–1.79 (m, 2 H), 1.69–1.64 (m, 2 H); 13C NMR (125 MHz, 
CDCl3) δ 198.1, 137.5, 136.5, 132.9, 131.8, 129.7, 128.6, 128.5, 128.3, 127.7, 126.5, 77.0, 73.7, 
45.1, 35.1, 25.0, 24.9, 18.5; IR (film) 3052, 2979, 1684, 1597, 1448, 1264, 909 cm-1. MS (ESI) 
343.1682 (343.1669 calcd for C22H24O2, M + Na+). 
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(3R*,4S*)-4-(4-Bromophenyl)-4-methoxy-3-phenylbutan-2-one (26). The reaction of 4-
bromobenzaldehyde (40 mg, 0.22 mmol) with 3-phenyl-1-propyne (40 µl, 0.32 mmol) and 
methanol (27 µl, 0.66 mmol) was conducted according to the general procedure. The crude 
product was formed as a 3:1 mixture of diastereomers as judged by 1H NMR analysis. 
Purification by flash chromatography afforded 48 mg (65%) of the title compound as a white 
solid with >20:1 dr. In addition, a small amount of the minor diastereomer (10 mg, 14%) was 
also isolated. 
Major (3R*,4S*) diastereomer: 1H NMR (500 MHz, CDCl3) δ 7.25 (d, J = 8.5 Hz, 2 H), 7.14–
7.13 (m, 3 H), 6.99–6.98 (m, 2 H), 6.89 (d, J = 8.5 Hz, 2 H), 4.74 (d, J = 10.0 Hz, 1 H), 3.92 (d, J 
= 10.5 Hz, 1 H), 3.19 (s, 3 H), 2.21 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 206.7, 138.0, 133.9, 
131.0, 129.0, 128.9, 128.6, 127.6, 121.4, 84.4, 65.8, 56.9, 30.9; IR (film) 3053, 1714, 1264, 
1101 cm–1. MS (ESI) 355.0310 (355.0304 calcd for C17H17BrO2, M + Na+). 
Minor (3R*,4R*)-diastereomer: 1H NMR (500 MHz, CDCl3) δ 7.45 (d, J = 8.5 Hz, 2 H), 7.35 (m, 
5 H), 7.22 (d, J = 8.5 Hz, 2 H), 4.75 (d, J = 8.5 Hz, 1 H), 3.96 (d, J = 9.0 Hz, 1 H), 3.03 (s, 3 H), 
1.07 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 206.3, 139.4, 135.5, 131.4, 129.4, 129.0, 128.7, 
127.6, 121.8, 82.8, 66.6, 56.9, 30.5; IR (film) 3053, 1715, 1421, 1265, 895 cm–1. MS (ESI) 
355.0311 (355.0304 calcd for C17H17BrO2, M + Na+). 
 
 
(2S,3R*,4S*)-4-(4-Bromophenyl)-4-(2-methylbutoxy)-3-phenylbutan-2-one (27). The 
reaction of 4-bromobenzaldehyde (40 mg, 0.22 mmol) with 3-phenyl-1-propyne (40 µl, 0.32 
mmol) and (S)-2-methylbutan-1-ol (71 µl, 0.66 mmol) was conducted according to the general 
procedure. This procedure afforded 65 mg (76%) of the title compound as a 3:3:1:1 mixture of 
diastereomers that were inseparable by flash chromatography. Data are for the mixture. 1H 
NMR (400 MHz, CDCl3) δ 7.43 (d, J = 8.5 Hz, 0.7 H), 7.32–7.31 (m, 1.32 H), 7.24 (d, J = 8.5 Hz, 
1.7 H), 7.20 (d, J =8.0 Hz, 0.7 H), 7.14–7.13 (m, 2 H), 7.03–7.01 (m, 1.4 H), 6.89 (d, J = 8.5 Hz, 
1.4 H), 4.79 (d, J = 10.0 Hz, 1 H), 3.94 (d, J = 10.5 Hz, 1 H), 3.16–3.02 (m, 1.7 H), 2.88-2.80 (m, 
0.3 H), 2.23 (s, 2 H), 1.89 (s, 1H), 1.57–1.54 (m, 0.7 H), 1.40-1.34 (m, 1 H), 1.16-1.06 (m, 1 H), 
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0.88–0.82 (m, 6.4 H), 0.67–0.64 (m, 1 H), 0.59-0.57 (m, 1 H). 13C NMR (125 MHz) 206.1, 206.4, 
140.1, 138.8, 134.1, 131.5, 131.3, 130.9, 129.5, 129.3, 129.2, 128.9, 128.8, 128.5, 128.3, 127.4, 
127.3, 121.5, 121.3, 83.3, 83.2, 81.4, 81.3, 74.4, 74.3, 74.1, 74.0, 66.8, 66.7, 65.8, 35.0, 34.9, 
34.8, 34.6, 31.2, 30.6, 26.1, 26.0, 25.8, 25.7, 16.6, 16.5, 16.4, 16.2, 11.2, 11.1, 10.9; IR (film) 
3053, 2962, 1717, 1264, 1071, 1010 cm-1. MS (ESI) 411.0939 (411.0930 calcd for C21H25BrO2, 
M + Na+). 
 
 
3-(4-Bromophenyl)-1-[4-(tert-butyl)phenyl]-3-methoxypropan-1-one (30). The reaction of 4-
bromobenzaldehyde (37 mg, 0.2 mmol) with 4-(tert-butyl)phenylacetylene (54.1 µL, 0.3 mmol) 
and methanol (24 µL, 0.6 mmol) was conducted according to the general procedure. Flash 
chromatography yielded a mixture of the title compound and 4’-(tert-butyl)acetophenone. The 
ketone impurity was removed by placing the impure product under vacuum at 0.25 torr for 36 
hrs.  This procedure afforded 30.0 mg (40%) of the title compound as a clear colorless oil. 1H 
NMR (500 MHz, CDCl3) δ 7.86 (d, J = 8.5 Hz, 2 H), 7.50–7.45 (m, 4 H), 7.29 (d, J = 8.0 Hz, 2 
H), 4.85 (dd, J = 5.0, 8.0 Hz, 1 H), 3.54 (dd, J = 8.0, 16.5 Hz, 1 H), 3.22 (s, 3 H), 3.05 (dd, J = 
5.0, 16.5 Hz, 1 H), 1.33 (s, 9 H); 13C NMR (125 MHz, CDCl3) δ 196.9, 157.0, 140.6, 134.4, 
131.7, 128.5, 128.1, 125.5, 121.6, 79.0, 56.9, 46.8, 35.1, 31.0; IR (film) 1680 cm–1. MS (ESI) 
397.0769 (397.0774 calcd for C20H23BrO2, M + Na+). 
 
 
1-[4-(tert-Butyl)phenyl]-3-methoxy-3-phenylpropan-1-one (32). The reaction of 
benzaldehyde (20.4 µL, 0.2 mmol) with 4-(tert-butyl)phenylacetylene (54.1 µL, 0.3 mmol) and 
methanol (24 µL, 0.6 mmol) was conducted according to the general procedure. Flash 
chromatography yielded a mixture of the title compound and 4’-(tert-butyl)acetophenone. The 
ketone impurity was removed by placing the impure product under vacuum at 0.25 torr for 48 h.  
This procedure afforded 36.8 mg (62%) of the title compound as a clear colorless oil. 1H NMR 
(500 MHz, CDCl3) δ 7.90 (d, J = 8.5 Hz, 2 H), 7.47 (d, J = 9.0 Hz, 2 H), 7.43–7.37 (m, 4 H), 
7.33-7.29 (m, 1 H), 4.90 (dd, J = 4.5, 8.5 Hz, 1 H), 3.59 (dd, J = 8.5, 16.5 Hz, 1 H), 3.24 (s, 3 H), 
3.08 (dd, J = 4.5, 16.5 Hz, 1 H), 1.34 (s, 9 H); 13C NMR (125 MHz, CDCl3) δ 197.0, 156.8, 141.5, 
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134.6, 128.5, 128.2, 127.8, 126.7, 125.5, 79.6, 56.9, 47.0, 35.1, 31.0; IR (film) 1684 cm–1. MS 
(ESI) 319.1669 (319.1669 calcd for C20H24O2, M + Na+). 
 
 
3-(4-Bromophenyl)-3-hydroxy-1-phenylpropan-1-one (34). A flame-dried flask was cooled 
under a stream of N2 and charged with diisopropylamine (169 µL, 1.2 mmol) and THF (5 mL). 
The flask was cooled to 0 °C and n-BuLi (0.79 mL, 1.4 M in hexanes, 1.1 mmol) was added 
slowly. After stirring for 10 min at 0 °C, acetophenone (122 µL, 1.0 mmol) was added to the 
reaction flask and the mixture was stirred at 0 OC for 30 min. 4-Bromobenzaldehyde (278 mg, 
1.5 mmol) was added to the reaction flask and the mixture was stirred for at 0 OC for 1 hr. The 
reaction was quenched slowly with saturated aqueous ammonium chloride (5 mL) at 0 OC and 
gradually warmed to rt. The mixture was transferred to a separatory funnel, extracted with ethyl 
acetate (5 mL), and the layers were separated. The organic layer was dried over anhydrous 
sodium sulfate, filtered, and concentrated in vacuo. The crude material was purified by flash 
chromatography on silica gel to afford 97 mg (32%) of the title compound as a white solid with 
spectroscopic properties identical to those previously reported.[2] 1H NMR (500 MHz, CDCl3) 
δ 7.96 (d, J = 8.5 Hz, 2 H), 7.61 (t, J = 7.5 Hz, 1 H), 7.52-7.47 (m, 4H), 7.33 (d, J = 8.0 Hz, 2 H), 
5.32 (dt, J = 3.0, 8.5 Hz, 1 H), 3.65 (d, J = 3 Hz, 1 H), 3.36-3.34 (m, 2 H). 
 
Assignment of Stereochemistry of 26 and 27 
The relative stereochemistry assignments of anti for compounds 26 and 27 were assigned 





[1] a) N. Mezailles, L. Ricard, R. Gagosz, Org. Lett. 2005, 7, 4133. b) L. Ricard, F. Gagosz, 
Organometallics 2007, 26, 4704. 
[2] C. H. Cheon, H. Yamamoto, Tetrahedron 2010, 66, 4257–4264.  




























































































   
 Data Collected on:
   Sn.Chem.LSA.UMich.edu-inova500
 Archive directory:
   
 Sample directory:
   
 FidFile: NRB-4-73-1H
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Aug 31 2012
Operator: nbabij
 Relax. delay 0.500 sec
 Pulse 45.0 degrees
 Acq. time 3.500 sec
 Width 7998.4 Hz
 16 repetitions
OBSERVE   H1, 499.9042609 MHz
DATA PROCESSING
 Line broadening 0.3 Hz
FT size 65536

















   
 Data Collected on:
   Sn.Chem.LSA.UMich.edu-inova500
 Archive directory:
   
 Sample directory:
   
 FidFile: NRB-4-73-13C
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Aug 31 2012
Operator: nbabij
 Relax. delay 0.100 sec
 Pulse 45.0 degrees
 Acq. time 2.086 sec
 Width 31421.8 Hz
 384 repetitions
OBSERVE  C13, 125.7010278 MHz
DECOUPLE  H1, 499.9067532 MHz




 Line broadening 1.0 Hz
FT size 131072










   
 Data Collected on:
   Sn.Chem.LSA.UMich.edu-inova500
 Archive directory:
   
 Sample directory:
   
 FidFile: PROTON
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3


















   
 Data Collected on:
   Sn.Chem.LSA.UMich.edu-inova500
 Archive directory:
   
 Sample directory:
   
 FidFile: NRB-4-77-13C
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3







	   	  
 Sample Name:
   
 Data Collected on:
   Sn.Chem.LSA.UMich.edu-inova500
 Archive directory:
   
 Sample directory:
   
 FidFile: NRB-4-69-1H
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Sep 10 2012
1.97
1.00
4.03
2.02
1.00
0.97
1.96
ppm012345678
Ph
OOH
Br
34
